However, IL-6 is the most consistently elevated cytokine in the blood of patients with MDD (45), and the IL-6 concentration may serve as a predictive biomarker in depression treatment outcomes (plasma IL-6 is observed to be higher in antidepressant-resistant patients compared with antidepressant-responsive patients) (46). The gene discussed is IL6; the disease is depressive symptom measurement.